Keyphrases
125I
13%
Acute Myeloid Leukemia
23%
Adrenocortical
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
26%
Apoptosis
10%
Asialoglycoprotein Receptor (ASGPR)
21%
B Cells
11%
Bleeding
10%
Bone Marrow
11%
Brain Tumor
15%
C-X-C Chemokine Receptor Type 4 (CXCR4)
10%
Cell Surface
16%
Central Nervous System
12%
Chemotherapy
20%
Childhood Cancer Survivors
10%
Children's Oncology Group
12%
Chronic Granulomatous Disease
42%
Clinical Trials
14%
Complementary DNA (cDNA)
10%
Confidence Interval
22%
Cytochrome b
9%
Endocytosis
13%
Engraftment
10%
Flavocytochrome
10%
GATA4
34%
GATA6
13%
Gene Expression
13%
Gene Therapy
12%
Gene Transfer
11%
Glioblastoma
22%
Glioma
13%
Gp91phox
30%
Graft-versus-host Disease (GvHD)
35%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
Hematopoietic Cell Transplantation
33%
Hematopoietic Stem Cell Transplantation
17%
Hematopoietic Stem Cells
35%
Hemophilia
13%
Hepatoma Cells
13%
HepG2 Cells
11%
High Risk
15%
Hydroxyurea
11%
In Cancer
12%
Inflammation
12%
Late Effects
14%
Leukemia
15%
Lipoprotein Receptor-related Protein
11%
Low-density Lipoprotein Receptor
20%
Macrophages
14%
Marrow Transplantation
12%
Medulloblastoma
20%
Mouse Model
15%
Myelodysplastic Syndrome
11%
NADPH Oxidase
37%
NADPH Oxidase Activity
10%
NCCN Guidelines
9%
Neurofibromatosis Type 1 (NF-1)
23%
Neurofibromatosis Type I
18%
Neutrophils
39%
Nicotinamide Adenine Dinucleotide Phosphate Oxidase
10%
Odds Ratio
13%
Older Adults
23%
Oncology
13%
Overall Survival
16%
Oxidase
15%
P22phox
13%
Pediatric
50%
Pediatric Cancer
9%
Pediatric Oncology
15%
Pediatric Patients
26%
Phagocytes
14%
Platelets
26%
Rac2
14%
Receptor-mediated Endocytosis
11%
Reduced-intensity Conditioning
13%
Risk Factors
11%
Severe Combined Immunodeficiency
11%
Sex Differences
15%
Sickle Cell Anemia
20%
Sickle Cell Disease
100%
Stem Cell Transplantation
15%
Superoxide
11%
Superoxide Production
12%
Survivors
29%
Survivorship
11%
Thrombosis
15%
Transcription Factor
28%
Transfusion
12%
Transplantation
19%
Tumor
33%
Tumor Cells
11%
Tumorigenesis
10%
Ubiquitin
21%
Ubiquitin System
11%
United States
12%
Unrelated Donor
11%
Von Willebrand Disease
22%
Von Willebrand Factor
27%
X-linked
10%
X-linked Chronic Granulomatous Disease (X-CGD)
25%
Medicine and Dentistry
Acute Leukemia
6%
Acute Lymphoblastic Leukemia
13%
Acute Myeloid Leukemia
15%
Allograft
6%
Apoplexy
19%
B Cell
8%
Biological Marker
5%
Bleeding
17%
Blood Stasis
8%
Blood Transfusion
7%
Brain Infarction
8%
Cancer
13%
Cancer Therapy
6%
Carcinogenesis
6%
Cell Function
8%
Cell Therapy
10%
Cell Transplantation
33%
Central Nervous System
9%
Central Nervous System Tumor
7%
Childhood Cancer
32%
Chronic Granulomatous Disease
10%
Clinical Trial
14%
Clinician
20%
Conditioning
10%
Cord Blood
5%
Decision Making
5%
Disease
13%
Disease Predisposition
5%
Diseases
55%
Engraftment
9%
Event Free Survival
8%
Ganglioglioma
26%
Ganglioneuroblastoma
6%
Gene Expression
6%
Germinoma
7%
Glioblastoma
10%
Graft Versus Host Reaction
15%
Granulocyte Colony Stimulating Factor
5%
Haemophilia A
8%
Hematopoiesis
6%
Hematopoietic Cell
56%
Hematopoietic Stem Cell Transplantation
22%
Hemodynamic
5%
Hydroxyurea
9%
Immune Deficiency
6%
In Vitro
9%
Infarction
7%
Infection
10%
Intracranial Tumor
11%
Late Effect
12%
Leukemia
17%
Lung
6%
Magnetic Resonance Imaging
8%
Malignant Neoplasm
48%
Medicine
6%
Medulloblastoma
15%
Metastatic Carcinoma
5%
Methotrexate
6%
Myelodysplastic Syndrome
11%
Neoplasm
47%
Neurofibromatosis Type I
17%
Neutrophil
8%
Odds Ratio
10%
Oncology
28%
Overall Survival
16%
Oxidoreductase
8%
Patient with Sickle Cell Disease
7%
Pediatric Brain Tumor
6%
Pediatric Cancer
14%
Pediatrics
81%
Pediatrics Patient
21%
Platelet
22%
Plexiform Neurofibroma
5%
Posttransplant Lymphoproliferative Disease
6%
Prevalence
10%
Quality of Life
17%
Radiation Therapy
13%
Receptor
10%
Recurrent Disease
7%
Reduced Intensity Conditioning
8%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
8%
Severe Combined Immunodeficiency
5%
Sex Difference
8%
Sickle Cell
9%
Sickle-Cell Disease
88%
Stem Cell
5%
Stem Cell Therapy
9%
Stem Cell Transplant
5%
Systematic Review
6%
T Cell
9%
Thrombocytopenia
8%
Thrombosis
16%
Transcription Factor GATA 4
15%
Transcription Factor GATA 6
6%
Tumor Cell
5%
Tumor Progression
5%
Vascular Anomaly
9%
Von Willebrand Disease
17%
Von Willebrand Factor
20%
Wilms' Tumor
7%